Literature DB >> 21416032

A review of compliance to anti tuberculosis treatment and risk factors for defaulting treatment in Sub Saharan Africa.

B Castelnuovo1.   

Abstract

BACKGROUND: The aim of this study is to assess anti TB treatment compliance and the factors predictive for poor adherence in Sub-Saharan Africa in the last 10 years.
METHODS: We searched Medline for articles written in English using the terms: "Patient Compliance"[Mesh] OR "Medication Adherence"[Mesh])) AND "Tuberculosis"[Mesh]) AND "Africa South of the Sahara"[Mesh].
RESULTS: We identified 4 published manuscript and we included 1 study from the Infectious Diseases Institute. The proportion of patients defaulting varied from 11.3% (8) to 29.6%. Risk factors for defaulting treatment were: distance from the hospital, not being on the first course of TB medications, lack of repeated smears, unit transfer after the intensive phase, experiencing side effects, having no family support , poor knowledge about TB treatment, being more than 25 years old, and use of public transport.
CONCLUSIONS: This review reveals high rate of losses to follow up in Sub-Saharan Africa; the information currently available is however too heterogeneous to draw conclusions on the reasons for this high rate of defaulters. It is imperative to understand predictive factors for treatment default so that programs can implement specific measure to target the population at risk.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21416032      PMCID: PMC3052808     

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  6 in total

1.  Control of tuberculosis in Uganda: a tale of two districts.

Authors:  F Nuwaha
Journal:  Int J Tuberc Lung Dis       Date:  1999-03       Impact factor: 2.373

2.  Defaulting from DOTS and its determinants in three districts of Arsi Zone in Ethiopia.

Authors:  B Tekle; D H Mariam; A Ali
Journal:  Int J Tuberc Lung Dis       Date:  2002-07       Impact factor: 2.373

3.  WHO declares TB an emergency in Africa.

Authors: 
Journal:  Indian J Med Sci       Date:  2005-08

Review 4.  Interventions to reduce tuberculosis mortality and transmission in low- and middle-income countries.

Authors:  Martien W Borgdorff; Katherine Floyd; Jaap F Broekmans
Journal:  Bull World Health Organ       Date:  2002       Impact factor: 9.408

5.  Determinants of treatment adherence among smear-positive pulmonary tuberculosis patients in Southern Ethiopia.

Authors:  Estifanos Biru Shargie; Bernt Lindtjørn
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069

6.  An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment.

Authors:  Frederick A D Kaona; Mary Tuba; Seter Siziya; Lenganji Sikaona
Journal:  BMC Public Health       Date:  2004-12-29       Impact factor: 3.295

  6 in total
  33 in total

1.  Prevalence and factors associated with tuberculosis treatment outcome among hazardous or harmful alcohol users in public primary health care in South Africa.

Authors:  K Peltzer; J S Louw
Journal:  Afr Health Sci       Date:  2014-03       Impact factor: 0.927

Review 2.  Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action.

Authors:  Katherine A Sacksteder; Marina Protopopova; Clifton E Barry; Koen Andries; Carol A Nacy
Journal:  Future Microbiol       Date:  2012-07       Impact factor: 3.165

3.  Integration of HIV and TB services results in improved TB treatment outcomes and earlier prioritized ART initiation in a large urban HIV clinic in Uganda.

Authors:  Sabine M Hermans; Barbara Castelnuovo; Catherine Katabira; Peter Mbidde; Joep M A Lange; Andy I M Hoepelman; Alex Coutinho; Yukari C Manabe
Journal:  J Acquir Immune Defic Syndr       Date:  2012-06-01       Impact factor: 3.731

4.  Patient satisfaction with TB care clinical consultations in Kampala: a cross sectional study.

Authors:  Willy Ssengooba; Bruce Kirenga; Catherine Muwonge; Steven Kyaligonza; Samuel Kasozi; Frank Mugabe; Martin Boeree; Moses Joloba; Alphonse Okwera
Journal:  Afr Health Sci       Date:  2016-12       Impact factor: 0.927

Review 5.  Host-Directed Therapies for Tuberculosis.

Authors:  David M Tobin
Journal:  Cold Spring Harb Perspect Med       Date:  2015-05-18       Impact factor: 6.915

6.  Antimicrobial efflux pumps and Mycobacterium tuberculosis drug tolerance: evolutionary considerations.

Authors:  John D Szumowski; Kristin N Adams; Paul H Edelstein; Lalita Ramakrishnan
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

7.  Childhood tuberculosis: management and treatment outcomes among children in Northwest Ethiopia: a cross-sectional study.

Authors:  Zemene Tigabu Kebede; Belaynew Wasie Taye; Yohannes Hailu Matebe
Journal:  Pan Afr Med J       Date:  2017-05-10

8.  Incidence, time and determinants of tuberculosis treatment default in Yaounde, Cameroon: a retrospective hospital register-based cohort study.

Authors:  Eric Walter Pefura Yone; André Pascal Kengne; Christopher Kuaban
Journal:  BMJ Open       Date:  2011-11-24       Impact factor: 2.692

9.  Patient- and provider-level risk factors associated with default from tuberculosis treatment, South Africa, 2002: a case-control study.

Authors:  Alyssa Finlay; Joey Lancaster; Timothy H Holtz; Karin Weyer; Abe Miranda; Martie van der Walt
Journal:  BMC Public Health       Date:  2012-01-20       Impact factor: 3.295

10.  The rate of sputum smear-positive tuberculosis after treatment default in a high-burden setting: a retrospective cohort study.

Authors:  Florian M Marx; Rory Dunbar; Donald A Enarson; Nulda Beyers
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.